Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
about
In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine designAn interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccinesLong term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipientsThe osmotic stress response of split influenza vaccine particles in an acidic environment.Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virusEmerging influenza viruses and the prospect of a universal influenza virus vaccine.Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypesCurrent cell-based influenza vaccine production technology as pandemic contingency.Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig modelConserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.In silico-based vaccine design against Ebola virus glycoproteinPhage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogensRobust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coliInfluenza virus-specific neutralizing IgM antibodies persist for a lifetime.Comparative structural analysis of haemagglutinin proteins from type A influenza viruses: conserved and variable features.A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment.Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.The ubiquitination of the influenza A virus PB1-F2 protein is crucial for its biological functionChanges in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccinationImmunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse ModelsInduction of anti-influenza immunity by modified green fluorescent protein (GFP) carrying hemagglutinin-derived epitope structure.Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses.Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.Epitope specificity of anti-HA2 antibodies induced in humans during influenza infectionA novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.Generation of influenza A viruses as live but replication-incompetent virus vaccines.Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.
P2860
Q28481569-02290687-9395-4B2B-A9B7-424B8C4A6119Q28730453-E7824F19-3FB2-4D2A-9C2E-11A25D0DD331Q28741451-78D0CF19-99A1-40C4-8F2C-EF5201B0696CQ30354213-5565B4F2-20E7-44CD-B18D-D47F9107C777Q30355629-366DDC86-65A1-48BD-ACE7-78D3EECE1B00Q30372274-72C8D8D4-1845-4619-B941-C6F8B956B762Q30373963-2837B2FE-ED04-42BB-A87F-D1C4FFC21ECBQ30375348-67EB06E1-7B80-4EAD-A6B3-6CF60DA9EBA6Q30382230-A0E2BB84-B563-4212-A074-52E49930FC91Q30387699-2E871DE5-44BD-4547-8234-76D432E6E75DQ30397410-DB6C5BE9-9C13-445D-A79E-1DE7E82BEA14Q30403507-3375D24C-AEFE-446A-B5C7-76E1E9163590Q30410546-2DBA142B-A8A7-421E-B064-A2710EA445B0Q30414391-4EF29D71-9FDC-4706-9A55-FFB3E3B873ECQ30414515-47385219-F7CD-4FC5-A416-05AB7B94EB8EQ30414543-1B21A3FB-3239-4456-8643-4A8F2C0E2B7EQ30419476-776FFF14-39D7-4272-A9DE-6E7E30605631Q30430651-C6CA6193-9D71-4614-A769-3FB01DAD40CEQ30843053-A36A0AAC-4F2E-4690-B02C-27097D8B8693Q34401573-3BF664E4-B2AA-4D6C-A8F7-B23111F1A538Q34533990-87C65130-ECDF-46B5-9E37-9B2C7C7492A6Q34593000-9B7E335E-582E-45A8-9278-C7A4AD5B5D83Q34694454-4A67A10C-8878-4D90-8E2F-4FA087D07681Q34776559-571B19DE-59C2-4F7F-89E1-1619E4D6876BQ34947244-6E2BF484-492A-47B8-BF62-5A11B82CADB5Q35076683-1DA103A7-CAE0-43EE-9BD9-D0C65B2651C2Q35169258-2EC58FB0-284D-4982-A3B1-88C868237E3CQ35389727-7E5255BF-0356-4953-8406-F4C904AF84BBQ35878770-E4E98667-74AC-46C3-8DC6-202F2824AE3DQ36509894-432EABBE-3884-4EF6-B3C9-A037EABBECDCQ36620838-CC56C57A-61DD-464D-B83E-82513C4BC348Q36626140-98564D96-2759-434F-97DD-BE2BF8A38E54Q36679099-599A3C1B-B9D2-4DFB-9275-6B36F56CB07CQ36977642-9E8182CC-88CB-4AB1-81A2-94E86C167A66Q37053710-11EE29DD-A986-4B69-9823-A703158B753CQ37087170-AE29D88A-AED0-47ED-9A87-6E6116D06E82Q37547653-28665DF1-404C-4308-94E6-6824C523D63CQ38719567-82B9EE1B-F175-46F0-A301-44A889E097DAQ38726947-B4C8C402-66E8-482E-8902-932557F55519Q38768816-FCCB6C01-1C3D-4D29-AE7B-DD144C5AD702
P2860
Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Conserved epitopes of influenz ...... universal vaccine development
@ast
Conserved epitopes of influenz ...... universal vaccine development
@en
type
label
Conserved epitopes of influenz ...... universal vaccine development
@ast
Conserved epitopes of influenz ...... universal vaccine development
@en
prefLabel
Conserved epitopes of influenz ...... universal vaccine development
@ast
Conserved epitopes of influenz ...... universal vaccine development
@en
P2860
P356
P1433
P1476
Conserved epitopes of influenz ...... universal vaccine development
@en
P2093
Eva Varečková
Zuzana Staneková
P2860
P2888
P356
10.1186/1743-422X-7-351
P5008
P577
2010-11-30T00:00:00Z
P6179
1002448254